logo
AAT Bioquest

Histone deacetylase 8 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
VorinostatIC501020.0 [1]
VorinostatKi396.0 [1]
Trichostatin AIC50300.0 [1]
Trichostatin AKi69.65 [1]
Tubastatin AIC50854.0 [1]
Tubastatin AKi96.2 [1], 1697.0 [2]
N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamideIC5077.7 [1]
EntinostatIC5010000.0 [1]
PanobinostatIC50231.0 [1]
PanobinostatKi22.0 [1], 105.0 [2], 170.0 [3]
TubacinIC50854.0 [1], 1270.0 [2], 5000.0 [3]
TubacinKi143.1 [1], 170.0 [2]
BelinostatIC5070.0 [1], 200.0 [2], 353.0 [3]
BelinostatKi22.0 [1], 25.0 [2]
ApicidinIC50300.0 [1], 750.0 [2], 755.0 [3], 760.0 [4]
ApicidinKi49.0 [1]
RomidepsinIC5040.0 [1], 10000.0 [2], 50000.0 [3]
RomidepsinKi0.15 [1]
MocetinostatIC5010000.0 [1], 25000.0 [2], 35000.0 [3]
QuisinostatIC5064.4 [1], 169.0 [2], 217.0 [3]
QuisinostatKi0.5 [1], 24.0 [2]
DacinostatIC503.84 [1], 400.0 [2]
DacinostatKi340.0 [1]
RicolinostatIC50100.0 [1], 254.0 [2], 5000.0 [3]
4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamideIC5010000.0 [1], 20000.0 [2]
N-Hydroxy-3-[1-(phenylthio)methyl-1H-1,2,3-triazol-4-yl]benzamideIC5044.0 [1], 70.0 [2], 628.0 [3], 746.0 [4]
ScriptaidIC50300.0 [1], 6810.0 [2]
ScriptaidKi105.0 [1]
LargazoleIC501068.0 [1], 10000.0 [2], 30000.0 [3]
9,9,9-Trifluoro-8-Oxo-N-PhenylnonanamideIC501500.0 [1]
9,9,9-Trifluoro-8-Oxo-N-PhenylnonanamideKi33.0 [1], 7300.0 [2]
N-Hydroxy-2,2-diphenylacetamideIC5045000.0 [1], 66000.0 [2]
N-Hydroxy-6-[(2S,5S,8S,11S)-8-(1H-indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanamideIC50130.0 [1], 133.0 [2]
N-[4-[[3-Azido-5-(azidomethyl)phenyl]methoxy]phenyl]-N'-hydroxyoctanediamideIC507340.0 [1]
N-[4-[[3-Azido-5-(azidomethyl)phenyl]methoxy]phenyl]-N'-hydroxyoctanediamideKi6590.0 [1]
1-(1-Phenyl-1H-1,2,3-triazole-4-ylmethyl)-3-hydroxypyridine-2(1H)-thioneIC501570.0 [1]
(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trioneIC50102.0 [1], 228.4 [2]
AbexinostatKi280.0 [1]
PracinostatKi16.0 [1], 48.0 [2]
GivinostatKi39.0 [1]
3-Hydroxypyridine-2-thiolIC503675.0 [1]
CID 53344908IC503600.0 [1]
CID 53344908Ki2706.0 [1]
N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamideIC50250.0 [1]
N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamideKi173.0 [1]
Azumamide EIC503700.0 [1]
Azumamide EKi4400.0 [1]
N-Hydroxy-4-phenylbutanamideIC504000.0 [1]
N-Hydroxy-4-phenylbutanamideKi1850.0 [1]
N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamideIC506120.0 [1]
N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamideIC5030000.0 [1], 100000.0 [2]
N-Hydroxy-4-methoxy-3-phenylmethoxybenzamideIC5023.9 [1], 27.0 [2]
N'-Hydroxy-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamideIC502780.0 [1]
Largazole ThiolIC50102.0 [1]
6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamideIC503410.0 [1], 6800.0 [2]
CID 24853793IC501.0 [1], 5000.0 [2]
N-(4-Hydroxybiphenyl-3-yl)benzamideIC5050000.0 [1]
(2r)-2-Amino-3-(2,4-Dichlorophenyl)-1-(1,3-Dihydro-2h-Isoindol-2-Yl)propan-1-OneIC5090.0 [1], 1090.0 [2]
N-[1-[[3-Azido-5-(azidomethyl)phenyl]methyl]pyrazol-4-yl]-N'-hydroxyoctanediamideIC5017.0 [1]
(E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamideKi82.0 [1], 95.0 [2]
Hdac8-IN-1IC5027.0 [1], 27.2 [2]
(2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamideIC5093.0 [1], 137.0 [2]
5-(Pyridin-4-YL)-1H-imidazole-2-thiolIC50500.0 [1]
2-Hydroxy-7-phenyl-2,4,6-cycloheptatriene-1-oneKi0.53 [1], 1.09 [2]
(2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamideIC50316.0 [1]
(E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamideIC50162.0 [1], 590.0 [2]
N-(2-Amino-5-thiophen-2-ylphenyl)-4-methoxybenzamideIC5020000.0 [1]
(3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetroneIC502200.0 [1]
(4S,7S,10S,13S)-7-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-10-(6-oxooctyl)-1,5,8,11-tetrazabicyclo[11.3.0]hexadecane-2,6,9,12-tetroneIC5015.0 [1], 1500.0 [2]
(3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9,10-dimethyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetroneIC502000.0 [1], 2200.0 [2]
6-[(2S,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acidIC502300.0 [1]
(2R,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-5-(6-oxooctyl)-1,4,7,10,14,15-hexazabicyclo[10.3.0]pentadeca-12,14-diene-3,6,9-trioneIC50105.0 [1], 110.0 [2]
(3S,6R,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(4-oxohexylsulfanylmethyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetroneIC504900.0 [1], 4920.0 [2]
(3S,6R,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(3-oxopentylsulfanylmethyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetroneIC5010000.0 [1]
3-Hydroxy-1-benzyl-2(1H)-pyridinethioneIC501272.0 [1]
N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamideIC502100.0 [1]
5-[4-[[3-Azido-5-(azidomethyl)benzoyl]amino]phenyl]-N-[7-(hydroxyamino)-7-oxoheptyl]-1,2-oxazole-3-carboxamideIC50651.0 [1]
(1r,2r,3r)-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-CarboxamideIC501400.0 [1]
4-[4-[(3-Hydroxy-2-sulfanylidenepyridin-1-yl)methyl]phenyl]benzonitrileIC502075.0 [1]
1-[[4-[4-(Dimethylamino)phenyl]phenyl]methyl]-3-hydroxypyridine-2-thioneIC502858.0 [1]
3-Hydroxy-1-[[4-(4-methylphenyl)phenyl]methyl]pyridine-2-thioneIC50800.0 [1]
3-Hydroxy-1-[(4-phenylphenyl)methyl]pyridine-2-thioneIC504283.0 [1]
3-Hydroxy-1-[[4-(2-methylphenyl)phenyl]methyl]pyridine-2-thioneIC503105.0 [1]
1-[[1-[4-(Dimethylamino)phenyl]triazol-4-yl]methyl]-3-hydroxypyridine-2-thioneIC501868.0 [1]
3-[4-[(3-Hydroxy-2-sulfanylidenepyridin-1-yl)methyl]phenyl]benzonitrileIC501701.0 [1]
3-Hydroxy-1-[[4-(3-methylphenyl)phenyl]methyl]pyridine-2-thioneIC502496.0 [1]
N3-Hydroxy-N1-phenylbenzene-1,3-dicarboxamideIC50110.0 [1], 120.0 [2]
N-(2-Aminophenyl)-5-[1-[2-(3-nitrophenyl)ethyl]triazol-4-yl]thiophene-2-carboxamideIC50100000.0 [1]
(2S)-N'-Hydroxy-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-N-[3-(trifluoromethyl)phenyl]octanediamideIC5032.9 [1], 33.0 [2]
(2S)-N'-Hydroxy-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]-N-phenyloctanediamideIC5093.0 [1], 137.0 [2]
(2S)-N'-Hydroxy-N-(3-methylphenyl)-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]octanediamideIC5052.0 [1]
N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamideIC50690.0 [1]
(7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamideIC5080.0 [1]
N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamideIC503842.0 [1]
N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamideKi250.0 [1]
N-Hydroxy-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-1,2,3,4-tetrahydroquinoline-6-carboxamideIC50470.0 [1]
1-(4-(Pyridin-4-yl)benzyl)-3-hydroxypyridine-2-thioneIC502780.0 [1]
1-[6-(4-Phenyl-1H-1,2,3-triazole-1-yl)hexyl]-3-hydroxypyridine-2(1H)-thioneIC506751.0 [1], 6791.0 [2]
1-[5-[4-(3-Methylphenyl)-1H-1,2,3-triazole-1-yl]pentyl]-3-hydroxypyridine-2(1H)-thioneIC501660.0 [1]
1-[5-[4-(4-Cyanophenyl)-1H-1,2,3-triazole-1-yl]pentyl]-3-hydroxypyridine-2(1H)-thioneIC501465.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Histone deacetylase 8 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/histone-deacetylase-8-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Histone deacetylase 8 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/histone-deacetylase-8-inhibitors-ic50-ki.
BibTeXEndNoteRefMan